Showing results (21-30 of 263) with videos related to

Sort By:
Pageof 27
British Medical Journal (Clinical Research Ed.)|May 2, 1981
Multimodal treatment in operable breast cancer: five-year results of the CMF programmeA Rossi, G Bonadonna, P Valagussa, et al.
The New England Journal of Medicine|April 1, 1982
Alternating drug combinations in the treatment of advanced Hodgkin's diseaseA Santoro, G Bonadonna, V Bonfante, et al.
American Journal of Clinical Oncology|April 1, 1988
Mitoxantrone: an active agent in refractory non-Hodgkin's lymphomasE Bajetta, R Buzzoni, P Valagussa, et al.
Cancer Treatment Reports|April 1, 1982
Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent resultsG Bonadonna, A Santoro, V Bonfante, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 3, 1999
Putting taxanes to work in operable breast cancer: a search for selective indications from empirical studiesL Gianni, G Capri, P Valagussa, et al.
CA: a Cancer Journal for Clinicians|July 1, 1995
Primary chemotherapy in surgically resectable breast cancerG Bonadonna, P Valagussa, R Zucali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodesR Buzzoni, G Bonadonna, P Valagussa, et al.
Seminars in Hematology|April 1, 1988
Treatment strategies for Hodgkin's diseaseG Bonadonna, A Santoro, S Viviani, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1980
Estrogen-receptor status and response to chemotherapy in early and advanced breast cancerG Bonadonna, P Valagussa, G Tancini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Cyclophosphamide, methotrexate, and fluorouracil with and without doxorubicin in the adjuvant treatment of resectable breast cancer with one to three positive axillary nodesA Moliterni, G Bonadonna, P Valagussa, et al.
Pageof 27